Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

This study has been withdrawn prior to enrollment.

( Lack of recruitment )

Study NCT00403156 Information provided by Vitreous -Retina- Macula Consultants of New York

First Received: November 22, 2006 Last Updated: November 6, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given